2026-05-28T16:51:54Zhttps://riuma.uma.es/rest/oai/request

oai:riuma.uma.es:10630/343232026-02-03T10:51:24Zcom_10630_2254col_10630_37953

00925njm 22002777a 4500 dc Dávila, Guadalupe author Moyano, María Pilar author Edelkraut, Lisa author Moreno-Campos, Lorena author Berthier, Marcelo L author Torres-Prioris, María José author López-Barroso, Diana author 2020-07-31 Currently, language therapy is the only treatment for childhood aphasia (CA). This study explored using the cognitive-enhancing drug donepezil (DP) to improve language recovery in a 9-year-old girl with chronic anomic aphasia caused by left temporal-parietal brain injury. The study involved DP treatment alone, combined with intensive naming therapy (INT), and washout periods. Results showed that DP alone improved spontaneous speech, comprehension, repetition, and attention, while combining DP with INT further enhanced naming abilities. Improvements remained after treatment, and DP had no side effects, enabling the child to return to regular schooling. Further research is needed to confirm these findings. Dávila, G., Moyano, M. P., Edelkraut, L., Moreno-Campos, L., Berthier, M. L., Torres-Prioris, M. J., & López-Barroso, D. (2020). Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy. Frontiers in pharmacology, 11, 1144. https://doi.org/10.3389/fphar.2020.01144 https://hdl.handle.net/10630/34323 10.3389/fphar.2020.01144 Quimioterapia Afasia Niños -- Enfermedades Pharmacotherapy of traumatic childhood aphasia: beneficial effects of donepezil alone and combined with intensive naming therapy